These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 15590971

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
    Granfors MT, Wang JS, Kajosaari LI, Laitila J, Neuvonen PJ, Backman JT.
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence early insulin signaling.
    Algenstaedt P, Daneshi S, Schwarzloh B, Hennigs N, Hamann A, Hansen-Algenstaedt N, Beisiegel U.
    Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):491-8. PubMed ID: 14714271
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of protease inhibitors on basal and insulin-stimulated lipid metabolism, insulin binding, and signaling.
    Cammalleri C, Germinario RJ.
    J Lipid Res; 2003 Jan; 44(1):103-8. PubMed ID: 12518028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
    Vernochet C, Azoulay S, Duval D, Guedj R, Ailhaud G, Dani C.
    AIDS; 2003 Oct 17; 17(15):2177-80. PubMed ID: 14523274
    [Abstract] [Full Text] [Related]

  • 11. Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors.
    Ben-Romano R, Rudich A, Török D, Vanounou S, Riesenberg K, Schlaeffer F, Klip A, Bashan N.
    AIDS; 2003 Jan 03; 17(1):23-32. PubMed ID: 12478066
    [Abstract] [Full Text] [Related]

  • 12. [Effects of various HIV protease inhibitors on function of rat insulinoma cells].
    Zhou JQ, Li WP, Xiang Z, Schutt M.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 May 03; 35(3):251-4. PubMed ID: 16764025
    [Abstract] [Full Text] [Related]

  • 13. HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).
    Gupta A, Zhang Y, Unadkat JD, Mao Q.
    J Pharmacol Exp Ther; 2004 Jul 03; 310(1):334-41. PubMed ID: 15007102
    [Abstract] [Full Text] [Related]

  • 14. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L, Eagling VA, Back DJ.
    AIDS; 1999 Sep 10; 13(13):1623-7. PubMed ID: 10509562
    [Abstract] [Full Text] [Related]

  • 15. HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.
    Lenhard JM, Furfine ES, Jain RG, Ittoop O, Orband-Miller LA, Blanchard SG, Paulik MA, Weiel JE.
    Antiviral Res; 2000 Aug 10; 47(2):121-9. PubMed ID: 10996400
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Resistance to human immunodeficiency virus type 1 protease inhibitors.
    Boden D, Markowitz M.
    Antimicrob Agents Chemother; 1998 Nov 10; 42(11):2775-83. PubMed ID: 9797203
    [No Abstract] [Full Text] [Related]

  • 18. HIV protease inhibitors: suppression of insulin secretion by inhibition of voltage-dependent K+ currents and anion currents.
    Neye Y, Düfer M, Drews G, Krippeit-Drews P.
    J Pharmacol Exp Ther; 2006 Jan 10; 316(1):106-12. PubMed ID: 16162820
    [Abstract] [Full Text] [Related]

  • 19. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
    Dailly E, Thomas L, Kergueris MF, Jolliet P, Bourin M.
    J Chromatogr B Biomed Sci Appl; 2001 Jul 15; 758(2):129-35. PubMed ID: 11486821
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic interactions between HIV-1 protease inhibitors in rats: study on combinations of two kinds of HIV-1 protease inhibitors.
    Shibata N, Matsumura Y, Okamoto H, Kawaguchi Y, Ohtani A, Yoshikawa Y, Takada K.
    J Pharm Pharmacol; 2000 Oct 15; 52(10):1239-46. PubMed ID: 11092568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.